Promega's Anti-ACTIVE® MAPK pAb provides a novel and effective method for the study of complex signaling pathways, including activation of the mitogen-activated protein kinase (MAPK) enzymes ERK1 and ERK2. In this update, we demonstrate the utility of this antibody in Western blotting and immunocytochemistry.
Promega Notes 59, 43.
Melanie H. Cobb1 and Erik M. Schaefer2